NCT03980002 2019-06-10BDHCLL001Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2 Recruiting50 enrolled
NCT00801060 2015-10-02Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)BiogenPhase 2 Terminated40 enrolled